🇺🇸 FDA
Pipeline program

Research ENDS S-TA-U001

NPK016-N44DA

Phase 1 small_molecule completed

Quick answer

Research ENDS S-TA-U001 for Cigarette Smoking is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Cigarette Smoking
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials